Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Saira Khaderi"'
Autor:
Aaron P Thrift, Fasiha Kanwal, Yanhong Liu, Saira Khaderi, Amit G Singal, Jorge A Marrero, Nicole Loo, Sumeet K Asrani, Michelle Luster, Abeer Al-Sarraj, Jing Ning, Spiridon Tsavachidis, Xiangjun Gu, Christopher I Amos, Hashem B El-Serag
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0282309 (2023)
BackgroundPolygenic risk scores (PRS) hold the promise to refine prognostication in hepatocellular cancer (HCC). The few available HCC PRS include germline risk variants identified among individuals of mostly European ancestry, but data are lacking o
Externí odkaz:
https://doaj.org/article/3180c64b7d41459487fa74f67226b27d
Autor:
Anjiya Shaikh, MBBS, Karthik Goli, BS, Nicole E. Rich, MD, Jihane N. Benhammou, MD, PhD, Saira Khaderi, MD, PhD, Ruben Hernaez, MD, PhD, Vatche G. Agopian, MD, John M. Vierling, MD, Donghee Kim, MD, PhD, Aijaz Ahmed, MD, John A. Goss, MD, Abbas Rana, MD, Fasiha Kanwal, MD, MSHS, George Cholankeril, MD, MSECR,
Publikováno v:
Transplantation Direct, Vol 8, Iss 5, p e1313 (2022)
Background. To reduce the disparity in access to liver transplant (LT), United Network for Organ Sharing implemented an exception policy in May 2019, which capped hepatocellular carcinoma (HCC) exception score to the median Model for End-Stage Liver
Externí odkaz:
https://doaj.org/article/80f4df0ab8ef4f348409278ef721aecc
Autor:
Fasiha Kanwal, Saira Khaderi, Amit G. Singal, Jorge A. Marrero, Sumeet K. Asrani, Christopher I. Amos, Aaron P. Thrift, Jennifer R. Kramer, Xian Yu, Yumei Cao, Michelle Luster, Abeer Al-Sarraj, Jing Ning, Hashem B. El-Serag
Publikováno v:
Clinical Gastroenterology and Hepatology.
Autor:
Saira Khaderi, Fasiha Kanwal
Publikováno v:
Hepatology. 76:546-548
Autor:
Fasiha Kanwal, Saira Khaderi, Amit G. Singal, Jorge A. Marrero, Nicole Loo, Sumeet K. Asrani, Christopher I. Amos, Aaron P. Thrift, Xiangjun Gu, Michelle Luster, Abeer Al‐Sarraj, Jing Ning, Hashem B. El‐Serag
Publikováno v:
Hepatology (Baltimore, Md.).
Etiological risk factors for cirrhosis have changed in the last decade. It remains unclear to what extent these trends in cirrhosis risk factors have changed HCC risk.We used data from two contemporary, prospective multiethnic cohorts of patients wit
Autor:
Michael L. Volk, Christina Clarke, Sumeet K. Asrani, Saira Khaderi, Meena B. Bansal, Elliot B. Tapper, Chanda Ho, Raymond T. Chung, John Lake, Nicholas Lim, Brett E. Fortune, Ray Kim, Deepti Dronamraju, Fasiha Kanwal
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 20(5)
Autor:
Anjiya Shaikh, Karthik Goli, Nicole E. Rich, Jihane N. Benhammou, Saira Khaderi, Ruben Hernaez, Vatche G. Agopian, John M. Vierling, Donghee Kim, Aijaz Ahmed, John A. Goss, Abbas Rana, Fasiha Kanwal, George Cholankeril
Publikováno v:
Transplantation direct. 8(5)
To reduce the disparity in access to liver transplant (LT), United Network for Organ Sharing implemented an exception policy in May 2019, which capped hepatocellular carcinoma (HCC) exception score to the median Model for End-Stage Liver Disease (MEL
Autor:
Saira Khaderi
Publikováno v:
Clinics in Liver Disease. 23:1-10
This article discusses alcohol use throughout history. The discovery and cultivation of wine and beer and distillation of spirits are explored. The article spans prehistory, Egypt, Ancient Greece, Ancient Rome, Europe, and the Americas; and the relig
Autor:
Fasiha Kanwal, Saira Khaderi, Amit G. Singal, Jorge A. Marrero, Sumeet K. Asrani, Nicole Loo, Christopher I. Amos, Aaron P. Thrift, Jennifer R. Kramer, Xiangjun Gu, Michelle Luster, Abeer Alsarraj, Jing Ning, Hashem B. El-Serag
Publikováno v:
Gastroenterology. 162:S-1131
Autor:
Fasiha Kanwal, Ahmed Kaseb, Osama Aboelfotoh El Sayed, John A. Goss, Wael A. Yousry, Maha Mohsen Kamal El-Din, Mohamed Mohamed Bahaa El-Din, Saira Khaderi, Prasun K. Jalal, Mohamed Saleh Ismail, Manal M. Hassan
Publikováno v:
World Journal of Hepatology
BACKGROUND Recurrent hepatitis C virus (HCV) infection of transplanted liver allografts is universal in patients with detectable HCV viremia at the time of transplantation. Direct-acting antiviral (DAA) therapy has been adopted as the standard of car